Anticancer agent 270
Anticancer agent 270 (Compound 8e) is an inhibitor that acts on tubulin. Its IC50 value against MCF-7 breast cancer cells is 1.02 μM. Through a dual mechanism of action, namely inducing Apoptosis and destabilizing microtubules, it exerts significant anti-proliferative activity against breast cancer cells. Anticancer agent 270 can be applied to research in the field of cancer[1].
Product Specifications
UNSPSC
12352005
Target
Microtubule/Tubulin
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Field of Research
Cancer
Smiles
CC1=CC=C2C(C(C(C3=NN=C(SCC(C4=CC(OC)=C(OC)C(OC)=C4)=O)N3)=CO2)=O)=C1
Molecular Formula
C23H21N3O6S
Molecular Weight
467.49
References & Citations
[1]Saadh M J, et al. Design and synthesis of chromene-triazole hybrids via recyclable magnetic nanocatalyst: Potent dual-acting anticancer agents targeting apoptotic and microtubule dynamics[J]. Journal of Molecular Structure, 2025, 1338: 142093.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP2-98221JF646 0.1 mL
Rabbit Polyclonal Aminopeptidase A/ENPEP Antibody [Janelia Fluor 646]
Ask
View Details 042164-ML750 100 µL
Sox2, phosphorylated (pS249) (SOX2, Transcription factor SOX-2) (MaxLight 750) discontinued
Ask
View Details